Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...

Researchers from KU Leuven, the University of California Davis Medical Center, the University of Cologne, and over 20 ...

Candida auris is a dangerous fungal pathogen that has become a global health concern. It spreads easily in health care settings and can cause life-threatening infections, especially in patients with ...

Basilea already secured $29 million to develop its antifungals fosmanogepix and BAL2062, and the Swiss company announced this morning that it has confirmed it will also receive its next tranche of $39 ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Fungal infections are getting harder to treat as they grow more resistant to available drugs, according to research published ...

Discover 5 dangerous drug-resistant fungi posing epidemic threats. Learn how these deadly superbugs are spreading and what ...

Vietnam Invasive Fungal Infection Market Key Takeaways: The Vietnam Invasive Fungal Infection (IFI) market is experiencing significant growth propelled by factors such as an increasing incidence of ...

Brexafemme is the first antifungal in what is only the fourth antifungal class to reach the market, and has data showing activity in three of four MDR infections on the World Health Organization ...

Certain medications can affect your body's ability to tolerate hot weather. Diuretics, beta-blockers, and some antipsychotics ...

"For decades, clinicians have relied on a handful of antifungal classes, with few mechanisms of action and significant limitations due to spectrum of activity, drug toxicities, or drug-drug ...